X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4456) 4456
Book Review (511) 511
Publication (284) 284
Conference Proceeding (10) 10
Dissertation (4) 4
Magazine Article (4) 4
Book Chapter (2) 2
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4247) 4247
index medicus (4203) 4203
female (3076) 3076
male (2897) 2897
middle aged (2849) 2849
organoplatinum compounds - administration & dosage (2736) 2736
aged (2661) 2661
oncology (2555) 2555
organoplatinum compounds - adverse effects (2362) 2362
antineoplastic combined chemotherapy protocols - therapeutic use (2282) 2282
adult (2092) 2092
chemotherapy (1882) 1882
antineoplastic combined chemotherapy protocols - adverse effects (1831) 1831
oxaliplatin (1757) 1757
fluorouracil - administration & dosage (1519) 1519
cancer (1368) 1368
treatment outcome (1300) 1300
colorectal neoplasms - drug therapy (1299) 1299
organoplatinum compounds - therapeutic use (1272) 1272
antineoplastic agents - adverse effects (1029) 1029
leucovorin - administration & dosage (959) 959
colorectal cancer (954) 954
fluorouracil (927) 927
fluorouracil - adverse effects (924) 924
antineoplastic combined chemotherapy protocols - administration & dosage (900) 900
colorectal neoplasms - pathology (841) 841
aged, 80 and over (816) 816
leucovorin (794) 794
deoxycytidine - analogs & derivatives (778) 778
camptothecin - analogs & derivatives (777) 777
disease-free survival (741) 741
antineoplastic agents - therapeutic use (687) 687
cisplatin (662) 662
deoxycytidine - administration & dosage (640) 640
leucovorin - adverse effects (625) 625
neoplasm staging (607) 607
capecitabine (590) 590
drug administration schedule (590) 590
pharmacology & pharmacy (590) 590
camptothecin - administration & dosage (584) 584
care and treatment (575) 575
adenocarcinoma - drug therapy (560) 560
fluorouracil - therapeutic use (556) 556
retrospective studies (543) 543
irinotecan (540) 540
trial (519) 519
medicine & public health (513) 513
bevacizumab (511) 511
5-fluorouracil (508) 508
antineoplastic agents - administration & dosage (499) 499
survival rate (498) 498
metastasis (472) 472
fluorouracil - analogs & derivatives (464) 464
1st-line treatment (445) 445
research (437) 437
surgery (433) 433
therapy (422) 422
animals (415) 415
leucovorin - therapeutic use (415) 415
carcinoma (411) 411
liver neoplasms - secondary (397) 397
neoplasm metastasis (384) 384
survival (383) 383
antineoplastic agents (380) 380
hematology, oncology and palliative medicine (377) 377
carboplatin (372) 372
liver neoplasms - drug therapy (366) 366
prognosis (363) 363
dose-response relationship, drug (362) 362
analysis (350) 350
antimitotic agents (350) 350
survival analysis (342) 342
chemotherapy, adjuvant (330) 330
combination (329) 329
deoxycytidine - adverse effects (329) 329
colonic neoplasms - drug therapy (309) 309
combined modality therapy (309) 309
clinical trials (300) 300
colorectal neoplasms - mortality (299) 299
drug therapy (299) 299
infusions, intravenous (297) 297
organoplatinum compounds - pharmacology (296) 296
follow-up studies (295) 295
phase-ii (295) 295
camptothecin - adverse effects (292) 292
cancer research (291) 291
kaplan-meier estimate (291) 291
prospective studies (290) 290
stomach neoplasms - drug therapy (280) 280
lung neoplasms - drug therapy (278) 278
colorectal-cancer (277) 277
gemcitabine (271) 271
disease progression (270) 270
metastatic colorectal-cancer (270) 270
adenocarcinoma - pathology (269) 269
ovarian neoplasms - drug therapy (269) 269
toxicity (260) 260
cetuximab (259) 259
radiotherapy (250) 250
health aspects (246) 246
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4014) 4014
Japanese (223) 223
Chinese (87) 87
French (49) 49
German (34) 34
Spanish (15) 15
Italian (14) 14
Russian (13) 13
Korean (6) 6
Hungarian (2) 2
Czech (1) 1
Danish (1) 1
Hebrew (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of Oncology, ISSN 0923-7534, 03/2004, Volume 15, Issue 3, pp. 460 - 466
Journal Article
JAMA, ISSN 0098-7484, 06/2017, Volume 317, Issue 23, pp. 2392 - 2401
IMPORTANCE: Combining biologic monoclonal antibodies with chemotherapeutic cytotoxic drugs provides clinical benefit to patients with advanced or metastatic... 
MEDICINE, GENERAL & INTERNAL | LEUCOVORIN | FIRE-3 | THERAPY | FOLFIRI PLUS CETUXIMAB | PHASE-II | IRINOTECAN | OXALIPLATIN | FLUOROURACIL | TUMORS | PROGRESSION | Leucovorin - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Bevacizumab - therapeutic use | United States | Bevacizumab - adverse effects | Colorectal Neoplasms - genetics | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Antineoplastic Agents - therapeutic use | Cetuximab - therapeutic use | Cetuximab - adverse effects | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Leucovorin - adverse effects | Fluorouracil - adverse effects | Antineoplastic Agents - adverse effects | Colorectal Neoplasms - drug therapy | Aged, 80 and over | Angiogenesis Inhibitors - therapeutic use | Adult | Camptothecin - administration & dosage | Female | Angiogenesis Inhibitors - adverse effects | Camptothecin - analogs & derivatives | Colorectal Neoplasms - mortality | Camptothecin - adverse effects | Kaplan-Meier Estimate | Treatment Outcome | Canada | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Colorectal Neoplasms - secondary | Aged | Genes, ras | Organoplatinum Compounds - adverse effects | Chemotherapy | Usage | Care and treatment | Research | Colorectal cancer | Cancer | Drugs | Medical research | Colorectal carcinoma | Clinical trials | Cytotoxicity | Patients | Survival | K-Ras protein | Bevacizumab | Metastases | Survival analysis | Irinotecan | Randomization | Oxaliplatin | Monoclonal antibodies | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2014, Volume 371, Issue 17, pp. 1609 - 1618
In patients with metastatic colon cancer, fluorouracil, oxaliplatin, and irinotecan plus bevacizumab, as compared with fluorouracil and irinotecan plus... 
1ST-LINE TREATMENT | MEDICINE, GENERAL & INTERNAL | INFUSIONAL FLUOROURACIL | LEUCOVORIN | MANAGEMENT | PHASE-III | GUIDELINES | IRINOTECAN | OXALIPLATIN | CHEMOTHERAPY | FOLFIRI | Follow-Up Studies | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Bevacizumab | Fluorouracil - therapeutic use | Antibodies, Monoclonal, Humanized - administration & dosage | Leucovorin - adverse effects | Fluorouracil - adverse effects | Neoplasm Metastasis - drug therapy | Colorectal Neoplasms - drug therapy | Adult | Female | Leucovorin - therapeutic use | Liver Neoplasms - secondary | Camptothecin - analogs & derivatives | Colorectal Neoplasms - mortality | Antibodies, Monoclonal, Humanized - adverse effects | Camptothecin - adverse effects | Camptothecin - therapeutic use | Kaplan-Meier Estimate | Liver Neoplasms - drug therapy | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Colorectal Neoplasms - pathology | Organoplatinum Compounds - therapeutic use | Organoplatinum Compounds - adverse effects | Treatment outcome | Care and treatment | Analysis | Colorectal cancer | Dosage and administration | Leucovorin | Fluorouracil | Colorectal carcinoma | Diarrhea | Metastasis | Survival | Patients | Clinical outcomes | Metastases | Irinotecan | Stomatitis | Chemotherapy | Neurotoxicity | Oxaliplatin | Monoclonal antibodies | Vascular endothelial growth factor | Neutropenia | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2009, Volume 27, Issue 5, pp. 663 - 671
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 04/2008, Volume 26, Issue 12, pp. 2013 - 2019
Journal Article
Annals of Oncology, ISSN 0923-7534, 05/2005, Volume 16, Issue 5, pp. 762 - 766
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2010, Volume 11, Issue 1, pp. 38 - 47
Summary Background Neoadjuvant chemotherapy for unresectable colorectal liver metastases can downsize tumours for curative resection. We assessed the... 
Hematology, Oncology and Palliative Medicine | SURVIVAL | 1ST-LINE TREATMENT | LEUCOVORIN | PLUS IRINOTECAN | ONCOLOGY | BEVACIZUMAB | OXALIPLATIN | FLUOROURACIL | HEPATIC RESECTION | CANCER | CARCINOMA | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Antineoplastic Agents - therapeutic use | Tomography, Spiral Computed | Liver Neoplasms - chemistry | Hepatectomy | Antibodies, Monoclonal, Humanized | Fluorouracil - therapeutic use | Austria | Leucovorin - adverse effects | Fluorouracil - adverse effects | Time Factors | Antineoplastic Agents - adverse effects | Female | Leucovorin - therapeutic use | Neoadjuvant Therapy | Retrospective Studies | Chemotherapy, Adjuvant | Cetuximab | Liver Neoplasms - secondary | Odds Ratio | Camptothecin - analogs & derivatives | Camptothecin - adverse effects | Camptothecin - therapeutic use | Liver Neoplasms - genetics | Risk Assessment | Liver Neoplasms - drug therapy | Linear Models | Liver Neoplasms - surgery | Proto-Oncogene Proteins - genetics | Treatment Outcome | Receptor, Epidermal Growth Factor - analysis | Magnetic Resonance Imaging | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Proto-Oncogene Proteins B-raf - genetics | Aged | Mutation | Colorectal Neoplasms - pathology | Organoplatinum Compounds - therapeutic use | Germany | Organoplatinum Compounds - adverse effects | Index Medicus
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2016, Volume 34, Issue 15, pp. 1723 - 1731
Journal Article
Annals of Oncology, ISSN 0923-7534, 2014, Volume 25, Issue 7, pp. 1346 - 1355
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 12, pp. 1389 - 1396
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2010, Volume 28, Issue 31, pp. 4697 - 4705
Purpose Panitumumab, a fully human anti-epidermal growth factor receptor (EGFR) monoclonal antibody that improves progression-free survival (PFS), is approved... 
KRAS MUTATIONS | MCRC | ONCOLOGY | STATISTICS | CETUXIMAB PLUS IRINOTECAN | CHEMOTHERAPY CT | OPEN-LABEL | COMBINATION | Leucovorin - administration & dosage | Predictive Value of Tests | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prospective Studies | Colorectal Neoplasms - genetics | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Gene Expression Regulation, Neoplastic | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Leucovorin - adverse effects | Fluorouracil - adverse effects | Colorectal Neoplasms - drug therapy | Aged, 80 and over | Adult | Female | Chemotherapy, Adjuvant | Colorectal Neoplasms - metabolism | Colorectal Neoplasms - mortality | Drug Administration Schedule | Kaplan-Meier Estimate | Proto-Oncogene Proteins - genetics | Treatment Outcome | Disease-Free Survival | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Aged | Biomarkers, Tumor - genetics | Infusions, Intravenous | Mutation | Colorectal Neoplasms - pathology | Neoplasm Staging | Organoplatinum Compounds - adverse effects | Index Medicus
Journal Article